Clearstead Trust’s Adient ADNT Stock Holding History

Clearstead Trust’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-31	Closed	-$399	–	1490
2025 Q1	$399	Buy	+31	New	+$498	﹤0.01%	858

Other funds holding ADNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HHAM

HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clearstead Trust's ADNT Position: Q2 2025 in Review

Clearstead Trust sold out of Adient (ADNT) in Q2 2025, closing a stake of 31 shares — an estimated $399 sold.

Clearstead Trust first reported a position in ADNT in Q1 2025 and held it in 1 quarter. The position peaked at $399 in Q1 2025. 266 funds tracked by Wall St. Rank hold ADNT as of Q2 2025.

Clearstead Trust reported no remaining Adient position as of Q2 2025 after selling out during the quarter.
Clearstead Trust sold 31 Adient shares in Q2 2025, an estimated $399.
Clearstead Trust first reported a position in Adient in Q1 2025 and held it in 1 quarter.
Clearstead Trust's Adient position peaked at $399 in Q1 2025.
266 funds tracked by Wall St. Rank held Adient as of Q2 2025.

Based on Clearstead Trust's 13F filing for Q2 2025, filed 8 Aug 2025.